Thomas Jefferson University, was awarded a four year $2.5 million grant from the National Institutes of Health Monday for a study of cancer gene activation in lung cancer. Researchers led by Dr. Eric Wickstrom, a professor of biochemistry and molecular biology at Jefferson Medical College of TJU, will use the grant funds to explore imaging techniques to highlight a gene — known as KRAS2 — involved in solid tumors in order to help direct cancer therapy to the gene. TJU is working with Molecular Targeting Technologies Inc. of West Chester, Pa., on the project.
The grant was awarded to TJU by the National Cancer Institute of NIH as part of its academic-industrial program for speeding discoveries to the bedside.
This is great news for the fight against cancer and TJU where Dennis Wright and Dr. Sato continue to perform laboratory testing, cell viability testing, and dosage response work on Wright's new invention. Perhaps a similar grant will be received soon to assist with this important research and to jump start the toxicology studies.
The grant was awarded to TJU by the National Cancer Institute of NIH as part of its academic-industrial program for speeding discoveries to the bedside.
This is great news for the fight against cancer and TJU where Dennis Wright and Dr. Sato continue to perform laboratory testing, cell viability testing, and dosage response work on Wright's new invention. Perhaps a similar grant will be received soon to assist with this important research and to jump start the toxicology studies.
